Rapid Polymerase Chain Reaction Assay to Detect Variation in the Extent of Gene‐specific Damage between Cisplatin‐ or VP‐16‐resistant and Sensitive Lung Cancer Cell Lines
Authors:
- 1 July 1994
- journal article
- research article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 85 (7) , 669-673
Abstract
We previously established a rapid and facile polymerase chain reaction (PCR)-stop assay for quantitation of specific gene damage in very small numbers of cells. The present study investigated whether the PCR-stop assay was able to detect variation in the extent of DNA damage in transcribed active genes between cisplatin- or VP-16-resistant and sensitive cells. The assay demonstrated that about twice as much genetic damage occurs in PC-9 cells than in cisplatin-resistant PC-9/CDDP cells following cisplatin exposure and about 4.6 times more damage occurs in H69 than in VP-16-resistant H69/VP cells following VP-16 exposure. These results show that DNA damage, as detected by PCR-stop assay, correlates with cytotoxicity. In conclusion, the PCR-stop assay could be useful in detecting variation in DNA damage in specific genes.Keywords
This publication has 19 references indexed in Scilit:
- A polymerase chain reaction-based method to detect cisplatin adducts in specific genesNucleic Acids Research, 1991
- Characterization of an etoposide-resistant human small-cell lung cancer cell lineCancer Chemotherapy and Pharmacology, 1990
- Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan familiesGenomics, 1990
- Determinants of Drug Response in a Cisplatin‐resistant Human Lung Cancer Cell LineJapanese Journal of Cancer Research, 1990
- The measurement of cisplatin-DNA adduct levels in testicular cancer patientsCarcinogenesis, 1988
- General method for quantifying base adducts in specific mammalian genes.Proceedings of the National Academy of Sciences, 1988
- Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy.Proceedings of the National Academy of Sciences, 1987
- Interindividual human variation in cisplatinum sensitivity, predictable in an in vitro assay?Mutation Research Letters, 1987
- The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexesPharmacology & Therapeutics, 1987
- DNA repair in an active gene: Removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overallCell, 1985